Internephron heterogeneity of growth factors and sclerosis—Modulation of platelet-derived growth factor by angiotensin II
- 1 January 1995
- journal article
- Published by Elsevier in Kidney International
- Vol. 47 (1) , 131-139
- https://doi.org/10.1038/ki.1995.15
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Angiotensin converting enzyme inhibitor modulates glomerular function and structure by distinct mechanismsKidney International, 1994
- Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass.Journal of Clinical Investigation, 1992
- Blood pressure-independent effect of angiotensin inhibition on vascular lesions of chronic renal failureKidney International, 1992
- Cause of variable therapeutic efficiency of angiotensin converting enzyme inhibitor on glomerular lesionsKidney International, 1991
- Long-term enalapril and verapamil in rats with reduced renal massKidney International, 1989
- Effects of antihypertensive drugs on glomerular morphologyKidney International, 1989
- Inhibitors of Angiotensin-Converting Enzyme Prevent Myointimal Proliferation After Vascular InjuryScience, 1989
- Glomerular hemodynamic changes vs. hypertrophy in experimental glomerular sclerosisKidney International, 1989
- Mechanisms underlying transition from acute glomerular injury to late glomerular sclerosis in a rat model of nephrotic syndrome.Journal of Clinical Investigation, 1988
- Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat.Journal of Clinical Investigation, 1986